APA (7th ed.) Citation

Dohrn, M. F., Beijer, D., Lone, M. A., Bayraktar, E., Oflazer, P., Orbach, R., . . . Zuchner, S. (2024). Recurrent de-novo gain-of-function mutation in SPTLC2 confirms dysregulated sphingolipid production to cause juvenile amyotrophic lateral sclerosis. Journal of neurology, neurosurgery and psychiatry, 95(3), 201-205. https://doi.org/10.1136/jnnp-2023-332130

Chicago Style (17th ed.) Citation

Dohrn, Maike F., et al. "Recurrent De-novo Gain-of-function Mutation in SPTLC2 Confirms Dysregulated Sphingolipid Production to Cause Juvenile Amyotrophic Lateral Sclerosis." Journal of Neurology, Neurosurgery and Psychiatry 95, no. 3 (2024): 201-205. https://doi.org/10.1136/jnnp-2023-332130.

MLA (9th ed.) Citation

Dohrn, Maike F., et al. "Recurrent De-novo Gain-of-function Mutation in SPTLC2 Confirms Dysregulated Sphingolipid Production to Cause Juvenile Amyotrophic Lateral Sclerosis." Journal of Neurology, Neurosurgery and Psychiatry, vol. 95, no. 3, 2024, pp. 201-205, https://doi.org/10.1136/jnnp-2023-332130.